EARLY VEDOLIZUMAB TROUGH LEVELS ARE NOT ASSOCIATED WITH A SHORT-TERM RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Pudilova, Karolina
Duricova, Dana
Kolar, Martin
Malickova, Karin
Hruba, Veronika
Machkova, Nadezda
Vanickova, Radka
Mitrova, Katarina
Lukas, Martin
Vasatko, Martin
Lukas, Milan
Bortlik, Martin
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1894
引用
收藏
页码：S877 / S877
页数：1
相关论文
共 50 条
  • [41] Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease
    Boden, Elisa K.
    Shows, Donna M.
    Chiorean, Michael V.
    Lord, James D.
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (09) : 2419 - 2429
  • [42] Predicting Response to Vedolizumab in Inflammatory Bowel Disease
    Meserve, Joseph
    Dulai, Parambir
    FRONTIERS IN MEDICINE, 2020, 7
  • [43] Infliximab trough levels are associated with disease activity in pediatric inflammatory bowel disease
    Hoekman, D. R.
    Brandse, J. F.
    de Meij, T. G.
    Hummel, T. Z.
    Lowenberg, M.
    Benninga, M. A.
    D'Haens, G. R. A. M.
    Kindermann, A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S412 - S412
  • [44] Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease
    Rodriguez-Lago, Iago
    Castro-Poceiro, Jesus
    Fernandez-Clotet, Agnes
    Mesonero, Francisco
    Lopez-Sanroman, Antonio
    Lopez-Garcia, Alicia
    Marquez, Lucia
    Clos-Parals, Ariadna
    Canete, Fiorella
    Vicuna, Miren
    Nantes, Oscar
    Merino, Olga
    Matallana, Virginia
    Gordillo, Jordi
    Elorza, Ainara
    Vicente, Raquel
    Jose Casanova, Maria
    Ferreiro-Iglesias, Rocio
    Perez-Galindo, Pablo
    Manuel Benitez, Jose
    Taxonera, Carlos
    Jose Garcia, Maria
    Martin, Eduardo
    Aguirre, Urko
    Gisbert, Javier P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (09) : 870 - 879
  • [45] Vedolizumab Trough Levels in Children With Anti-Tumor Necrosis Factor Refractory Inflammatory Bowel Disease
    Aardoom, Martine A.
    Jongsma, Maria M. E.
    de Vries, Annick
    Wolthoorn, Jasja
    de Ridder, Lissy
    Escher, Johanna C.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020, 71 (04): : 501 - 507
  • [46] Early vedolizumab trough levels are associated with induction therapy outcome
    O'Connell, J.
    Corcoran, R.
    Argue, R.
    McDonagh, P.
    Ismail, M. S.
    Cullen, G.
    Doherty, G.
    Hartery, K.
    Healy, M.
    McCormack, M.
    MacCarthy, F.
    McKiernan, S.
    O'Connor, A.
    Ryan, B.
    McNamara, D.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S580 - S580
  • [47] Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease
    Sekhri, Shaina
    Rao, Bharat
    Mohananey, Akanksha
    Beniwal-Patel, Poonam
    Bruss, Alexandra
    Stein, Daniel J.
    Yarur, Andres J.
    BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01):
  • [48] Which are the optimal adalimumab trough levels associated with biological remission in patients with inflammatory bowel disease?
    Serra, K.
    Rodriguez-Alonso, L.
    Padulles, N.
    Rodriguez-Moranta, F.
    Arajol, C.
    Gilabert, P.
    Rodriguez, R.
    Bas, J.
    Morandeira-Rego, F.
    Santacana, E.
    Padulles, A.
    Guardiola, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S358 - S358
  • [49] Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease
    van Hoeve, Karen
    Dreesen, Erwin
    Hoffman, Ilse
    Van Assche, Gert
    Ferrante, Marc
    Gils, Ann
    Vermeire, Severine
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (11): : 1316 - 1325
  • [50] SERUM INFLIXIMAB TROUGH LEVELS ARE NOT ASSOCIATED WITH ACTIVE PERIPHERAL ARTHRALGIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Sekhri, Shaina
    Rao, Bharat
    Mohananey, Akanksha
    Beniwal-Patel, Poonam
    Stein, Daniel J.
    Yarur, Andres J.
    GASTROENTEROLOGY, 2021, 160 (06) : S693 - S694
12345